← Browse by Condition
Medical Condition
carcinoma hepatocellular
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1, Phase 2
NCT06349980 Phase 2
Recruiting
A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.
Enrollment
117 pts
Location
China
Sponsor
Shanghai Henlius Biotech
NCT03812874 Phase 1, Phase 2
Recruiting
A Study of PTX-9908 Injection for Non-resectable HCC with TACE
Enrollment
50 pts
Location
Taiwan
Sponsor
TCM Biotech International Corp...